CLINICAL TRIALS PROFILE FOR HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL
✉ Email this page to a colleague
All Clinical Trials for HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00139698 ↗ | Olmesartan Alone or in Combination With Hydrochlorothiazide in Subjects With Mild to Moderate Essential Hypertension | Completed | Pfizer | Phase 3 | 2005-09-01 | Efficacy, tolerability and safety of olmesartan alone or in combination with hydrochlorothiazide in the treatment of mild to moderate essential hypertension |
| NCT00171015 ↗ | VALORY Study of Valsartan/Hydrochlorizide for Patients Who do Not Respond Adequately to Olmesartan Medoxomil | Completed | Novartis | Phase 3 | 2004-12-01 | To evaluate the efficacy of valsartan 160 mg/HCTZ 25 mg in patients not adequately responding to monotherapy with olmesartan medoxomil 40 mg or combination therapy with olmesartan medoxomil 20 mg plus HCTZ 12.5 mg by testing the hypothesis that valsartan 160 mg/HCTZ 25 mg significantly reduces the trough mean sitting diastolic blood pressure (MSDBP) after a 4-week treatment in the nonresponder population. |
| NCT00185068 ↗ | An Examination of the Safety and Blood Pressure Lowering Effect of Increasing Doses of Benicar® and Benicar® HCT in Patients With Hypertension | Completed | Daiichi Sankyo Inc. | Phase 4 | 2004-03-01 | Effect of increasing doses of olmesartan medoxomil and olmesartan medoxomil/hydrochlorothiazide on blood pressure in patients with hypertension |
| NCT00185068 ↗ | An Examination of the Safety and Blood Pressure Lowering Effect of Increasing Doses of Benicar® and Benicar® HCT in Patients With Hypertension | Completed | Daiichi Sankyo, Inc. | Phase 4 | 2004-03-01 | Effect of increasing doses of olmesartan medoxomil and olmesartan medoxomil/hydrochlorothiazide on blood pressure in patients with hypertension |
| NCT00185120 ↗ | Treatment of High Blood Pressure Using Olmesartan With Hydrochlorothiazide Compared to an ACE Inhibitor With a Calcium Channel Blocker | Completed | Daiichi Sankyo Inc. | Phase 4 | 2005-09-01 | A comparison of 2 different combinations of high blood pressure medications to treat hypertension |
| NCT00185120 ↗ | Treatment of High Blood Pressure Using Olmesartan With Hydrochlorothiazide Compared to an ACE Inhibitor With a Calcium Channel Blocker | Completed | Daiichi Sankyo, Inc. | Phase 4 | 2005-09-01 | A comparison of 2 different combinations of high blood pressure medications to treat hypertension |
| NCT00311155 ↗ | Olmesartan and an add-on Treatment in Patients With Mild to Moderate Hypertension | Completed | Sankyo Pharma Gmbh | Phase 4 | 2006-03-01 | This study is to assess the safety and efficacy of an add-on treatment algorithm with olmesartan, hydrochlorothiazide and amlodipine in patients with mild to moderate hypertension. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL
Condition Name
Clinical Trial Locations for HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL
Trials by Country
Clinical Trial Progress for HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL
Clinical Trial Phase
Clinical Trial Sponsors for HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL
Sponsor Name
